Stock listing
NYSE American:ATNM Actinium Pharmaceuticals, Inc. (Delaware) Stock
Home listing (NYSE American) of Actinium Pharmaceuticals, Inc. (Delaware)
Follow Actinium Pharmaceuticals, Inc. (Delaware) into a list and get an email when it puts out news.
Share price · AMEX:ATNM
$1.05 USD -0.02 (-1.9%)
Close on Nov 20, 2026
- Day range
- $1.00 – $1.10 USDNov 20, 2026
- Volume
- 280,659 sharesNov 20, 2026
- Market cap
- $33.01M USDAt the close on Nov 20, 2026 · price × 31.44M shares outstanding
- 52-week range
- $0.735 – $1.72 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $251,047 USDMedian day 115,250 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:ATNM · Home | $1.05 USD | -0.02 (-1.9%) | 280,659 | $1.07 | $1.10 | $1.00 | $1.07 | Close on Nov 20, 2026 |
| Frankfurt:7AY1 | €0.948 EUR | -0.017 (-1.8%) | — | €0.948 | €0.948 | €0.948 | €0.965 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · AMEX:ATNM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.05 | -0.02 | -1.9% | $1.07 | $1.10 | $1.00 | 280,659 | |
| $1.07 | -0.01 | -0.9% | $1.08 | $1.18 | $1.03 | 166,488 | |
| $1.08 | -0.27 | -20.0% | $1.33 | $1.34 | $1.08 | 326,840 | |
| $1.35 | -0.14 | -9.4% | $1.45 | $1.49 | $1.28 | 555,005 | |
| $1.49 | -0.15 | -9.1% | $1.64 | $1.685 | $1.465 | 347,947 | |
| $1.64 | +0.05 | +3.1% | $1.60 | $1.64 | $1.55 | 180,600 | |
| $1.59 | 0.00 | 0.0% | $1.61 | $1.67 | $1.53 | 348,100 | |
| $1.59 | +0.02 | +1.3% | $1.52 | $1.65 | $1.49 | 115,500 | |
| $1.57 | +0.03 | +1.9% | $1.55 | $1.61 | $1.50 | 176,400 | |
| $1.54 | +0.11 | +7.7% | $1.44 | $1.62 | $1.43 | 467,400 | |
| $1.43 | +0.13 | +10.0% | $1.28 | $1.43 | $1.28 | 89,200 | |
| $1.30 | -0.11 | -7.8% | $1.38 | $1.39 | $1.30 | 213,000 | |
| $1.41 | +0.01 | +0.7% | $1.42 | $1.45 | $1.36 | 104,300 | |
| $1.40 | -0.03 | -2.1% | $1.40 | $1.46 | $1.40 | 75,800 | |
| $1.43 | -0.05 | -3.4% | $1.48 | $1.53 | $1.41 | 104,600 | |
| $1.48 | -0.05 | -3.3% | $1.51 | $1.535 | $1.45 | 157,700 | |
| $1.53 | +0.15 | +10.9% | $1.38 | $1.56 | $1.38 | 181,700 | |
| $1.38 | -0.04 | -2.8% | $1.40 | $1.42 | $1.35 | 56,600 | |
| $1.42 | +0.02 | +1.4% | $1.40 | $1.55 | $1.40 | 107,000 | |
| $1.40 | -0.12 | -7.9% | $1.50 | $1.53 | $1.36 | 205,800 | |
| $1.52 | -0.08 | -5.0% | $1.60 | $1.63 | $1.469 | 242,000 | |
| $1.60 | +0.22 | +15.9% | $1.33 | $1.66 | $1.33 | 827,800 | |
| $1.38 | -0.02 | -1.4% | $1.38 | $1.409 | $1.33 | 357,900 | |
| $1.40 | +0.08 | +6.1% | $1.36 | $1.50 | $1.35 | 900,300 | |
| $1.32 | +0.19 | +16.8% | $1.14 | $1.40 | $1.13 | 657,200 | |
| $1.13 | +0.07 | +6.6% | $1.09 | $1.15 | $1.05 | 174,400 | |
| $1.06 | +0.085 | +8.7% | $0.95 | $1.07 | $0.95 | 143,200 | |
| $0.975 | -0.025 | -2.5% | $0.99 | $1.023 | $0.952 | 84,600 | |
| $1.00 | -0.06 | -5.7% | $1.07 | $1.07 | $0.996 | 87,900 | |
| $1.06 | -0.04 | -3.6% | $1.09 | $1.09 | $1.029 | 97,600 | |
| $1.10 | +0.02 | +1.9% | $1.09 | $1.12 | $1.07 | 105,800 | |
| $1.08 | +0.01 | +0.9% | $1.09 | $1.10 | $1.06 | 104,900 | |
| $1.07 | -0.04 | -3.6% | $1.08 | $1.12 | $1.05 | 100,100 | |
| $1.11 | -0.09 | -7.5% | $1.20 | $1.22 | $1.02 | 439,600 | |
| $1.20 | +0.03 | +2.6% | $1.16 | $1.24 | $1.16 | 115,000 | |
| $1.17 | +0.02 | +1.7% | $1.15 | $1.19 | $1.12 | 81,800 | |
| $1.15 | +0.03 | +2.7% | $1.11 | $1.15 | $1.11 | 90,800 | |
| $1.12 | -0.02 | -1.8% | $1.14 | $1.20 | $1.10 | 95,100 | |
| $1.14 | -0.04 | -3.4% | $1.17 | $1.17 | $1.14 | 62,022 | |
| $1.18 | -0.02 | -1.7% | $1.18 | $1.20 | $1.17 | 75,373 | |
| $1.20 | +0.01 | +0.8% | $1.19 | $1.205 | $1.18 | 28,400 | |
| $1.19 | +0.01 | +0.8% | $1.19 | $1.25 | $1.18 | 84,800 | |
| $1.18 | +0.01 | +0.9% | $1.17 | $1.21 | $1.16 | 130,400 | |
| $1.17 | -0.03 | -2.5% | $1.18 | $1.22 | $1.17 | 54,500 | |
| $1.20 | -0.02 | -1.6% | $1.24 | $1.24 | $1.166 | 99,400 | |
| $1.22 | +0.03 | +2.5% | $1.18 | $1.23 | $1.18 | 146,200 | |
| $1.19 | -0.05 | -4.0% | $1.26 | $1.26 | $1.18 | 56,700 | |
| $1.24 | -0.01 | -0.8% | $1.26 | $1.275 | $1.24 | 59,800 | |
| $1.25 | -0.03 | -2.3% | $1.28 | $1.32 | $1.25 | 96,100 | |
| $1.28 | -0.12 | -8.6% | $1.41 | $1.418 | $1.25 | 301,500 | |
| $1.40 | +0.09 | +6.9% | $1.31 | $1.42 | $1.285 | 238,200 | |
| $1.31 | +0.08 | +6.5% | $1.25 | $1.34 | $1.23 | 226,800 | |
| $1.23 | 0.00 | 0.0% | $1.24 | $1.305 | $1.22 | 366,600 | |
| $1.23 | +0.20 | +19.4% | $1.06 | $1.25 | $1.06 | 574,100 | |
| $1.03 | -0.02 | -1.9% | $1.05 | $1.055 | $1.02 | 54,000 | |
| $1.05 | +0.05 | +5.0% | $1.02 | $1.06 | $1.01 | 72,000 | |
| $1.00 | +0.004 | +0.4% | $1.00 | $1.04 | $1.00 | 74,900 | |
| $0.996 | -0.024 | -2.4% | $1.01 | $1.022 | $0.996 | 30,100 | |
| $1.02 | +0.01 | +1.0% | $1.03 | $1.03 | $1.01 | 34,800 | |
| $1.01 | +0.01 | +1.0% | $1.00 | $1.028 | $0.97 | 111,600 | |
| $1.00 | -0.01 | -1.0% | $1.01 | $1.05 | $1.00 | 92,900 | |
| $1.01 | -0.07 | -6.5% | $1.08 | $1.08 | $1.01 | 145,100 | |
| $1.08 | +0.03 | +2.9% | $1.07 | $1.10 | $1.05 | 159,003 | |
| $1.05 | -0.05 | -4.5% | $1.10 | $1.10 | $1.04 | 64,454 | |
| $1.10 | -0.02 | -1.8% | $1.13 | $1.14 | $1.10 | 143,800 | |
| $1.12 | -0.01 | -0.9% | $1.13 | $1.14 | $1.07 | 121,400 |
Splits
1 split · AMEX:ATNM · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-30 | Consolidation |
- Ticker
- NYSE American:ATNM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE American
- Currency
- USD
What changed lately
Latest news release · Nov 17, 2026
Actinium Pharmaceuticals Provides Third Quarter 2026 Corporate Update Highlighting ATNM-400 and Other Business Progress
Latest deck · November 2026
Actinium Pharmaceuticals — Investor Presentation (November 2026)
Investor deck · 36 slides
Latest news
Actinium Pharmaceuticals Provides Third Quarter 2026 Corporate Update Highlighting ATNM-400 and Other Business Progress
Nov 17, 2026
Closed $1.35 (-9.4%) on Nov 17, 2026
Actinium Pharmaceuticals to Host KOL Webinar on ATNM-400, a First-in-Class HER3-Targeted Alpha Radiotherapy
Nov 12, 2026
Closed $1.59 (0.0%) on Nov 12, 2026
Actinium Pharmaceuticals Announces Enrollment in the RADIANZ Imaging Clinical Trial Intended to Demonstrate the Pan-Cancer Potential of ATNM-400, A First-in-Class HER3-Targeting Radiotherapy
Nov 11, 2026
Closed $1.59 (+1.3%) on Nov 11, 2026
Actinium Pharmaceuticals Announces Formation of Scientific Advisory Board Featuring Leading Experts in Oncology and Radiopharmaceutical Development
Nov 9, 2026
Closed $1.54 (+7.7%) on Nov 9, 2026
Actinium Pharmaceuticals Announces Three ASH 2026 Abstracts Highlighting Iomab-ACT Clinical Results in CAR T-Cell Therapy and Sickle Cell Disease
Nov 4, 2026
Closed $1.41 (+0.7%) on Nov 4, 2026
Actinium Pharmaceuticals Announces ASH 2026 Abstract Highlighting Long-Term Results of Actimab-A in Combination with CLAG-M in Relapsed or Refractory AML
Nov 4, 2026
Closed $1.41 (+0.7%) on Nov 4, 2026
Actinium Pharmaceuticals Announces Acceptance of ATNM-400 Abstract for Presentation at SABCS 2026 Highlighting Activity Across Therapy-Resistant Breast Cancer Models
Nov 2, 2026
Closed $1.43 (-3.4%) on Nov 2, 2026
Actinium Pharmaceuticals Announces Inducement Grant to New Employee
Oct 30, 2026
Closed $1.43 (-3.4%) on Nov 2, 2026
Decks
Actinium Pharmaceuticals — Investor Presentation (November 2026)
Investor deck · 36 slides · November 2026
Actinium Pharmaceuticals — Technical Presentation (October 2026)
Technical · 12 slides · Oct 19, 2026
Actinium Pharmaceuticals — Investor Presentation (October 2026)
Investor deck · 26 slides · October 2026
Actinium Pharmaceuticals — 4th Annual Targeted Radiotherapeutics Summit 2025
Conference · 24 slides · Jul 30, 2025
Actinium Pharmaceuticals, Inc. (Delaware) on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 28 in the last 12 months · 39 in all · newest Nov 17, 2026 · oldest 2025
- Decks
- 24 decks · latest November 2026
Where Actinium Pharmaceuticals, Inc. (Delaware) is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:ATNM · Home listing · This page | NYSE American | United States | USD |
| Lang & Schwarz:A2QA48 | Lang & Schwarz | Germany | EUR |
| gettex:7AY1 | gettex | Germany | EUR |
| LS Exchange:A2QA48 | LS Exchange | Germany | EUR |
| Tradegate:7AY1 | Tradegate | Germany | EUR |
| BOATS:ATNM | BOATS | United States | USD |
| Stuttgart:7AY1 | Stuttgart | Germany | EUR |
| Dusseldorf:7AY1 | Dusseldorf | Germany | EUR |
| Frankfurt:7AY1 | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about Actinium Pharmaceuticals, Inc. (Delaware).